Russell Clayton
Hoofd Techniek/Wetenschap/O&O bij LARIMAR THERAPEUTICS, INC.
Vermogen: 180 000 $ op 31-05-2024
Momenteel actieve connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Michael Celano | M | 65 | 4 jaar | |
| Carole Ben-Maimon | M | 65 | 4 jaar | |
| John Berman | M | 57 | 7 jaar | |
| Jonathan Leff | M | 55 | 4 jaar | |
| Frank Thomas | M | 54 | 10 jaar | |
| Jeffrey Sherman | M | 69 | 1 jaar | |
| Joseph Truitt | M | 59 | 4 jaar | |
| Thomas Hamilton | M | 56 | 4 jaar | |
| Francis M. Conway | M | - | 4 jaar | |
| Jennifer Spokes Johansson | F | - | 8 jaar | |
| Noreen Scherer | F | - | 6 jaar | |
| Gopi Shankar | M | 53 | 1 jaar |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| John Tucker | M | 61 |
Alcresta Therapeutics, Inc.
 Alcresta Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Alcresta Therapeutics, Inc. engages in the development of enzyme-based products designed to address challenges faced by people living with gastrointestinal disorders and rare diseases. It offers products designed to improve the delivery, digestion, and absorption of long-chain polyunsaturated fatty acids or LCPUFAs. The company was founded by Robert Gallotto and Dr. Alexey L. Margolin in 2011 and is headquartered in Newton, MA. | 2 jaar |
| Anastasios Konidaris | M | 57 |
Alcresta Therapeutics, Inc.
Alcresta Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Alcresta Therapeutics, Inc. engages in the development of enzyme-based products designed to address challenges faced by people living with gastrointestinal disorders and rare diseases. It offers products designed to improve the delivery, digestion, and absorption of long-chain polyunsaturated fatty acids or LCPUFAs. The company was founded by Robert Gallotto and Dr. Alexey L. Margolin in 2011 and is headquartered in Newton, MA. | 4 jaar |
| Daniel Tassé | M | 64 |
Alcresta Therapeutics, Inc.
Alcresta Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Alcresta Therapeutics, Inc. engages in the development of enzyme-based products designed to address challenges faced by people living with gastrointestinal disorders and rare diseases. It offers products designed to improve the delivery, digestion, and absorption of long-chain polyunsaturated fatty acids or LCPUFAs. The company was founded by Robert Gallotto and Dr. Alexey L. Margolin in 2011 and is headquartered in Newton, MA. | 2 jaar |
| Nancy Ruiz | M | - | 3 jaar |
Statistieken
| Land | Connecties | % van het totaal |
|---|---|---|
| Verenigde Staten | 16 | 100.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Russell Clayton
- Persoonlijk netwerk
